Yahoo Web Search

Search results

1. Hikma Pharmaceuticals PLC

   LSE: HIK.L

   1,907.00

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   +2.00 (+0.10%)

   · Delayed Quote (GBp) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	1,916.00
     High	1,927.00
     Low	1,898.00

   • Mkt Cap	4.23B
     P/E (TTM)	28.89
     Div & Yield	0.57 & 3.01%

   • Prev. Close	1,905.00
     52 Wk. Low	1,711.00
     52 Wk. High	2,222.00

   More about HIK.L

   Related stocks

   • ITRK.L
     Intertek Group plc
     ITRK.L
     4,830.00
     -1.51%
   • MNDI.L
     Mondi plc
     MNDI.L
     1,554.00
     -2.75%
   • HLMA.L
     Halma plc
     HLMA.L
     2,226.00
     -1.42%
   • BNZL.L
     Bunzl plc
     BNZL.L
     2,974.00
     -0.34%
   • CRDA.L
     Croda International Plc
     CRDA.L
     4,530.00
     -1.07%

   More on Yahoo Finance

2. stockanalysis.com › quote › lonHikma Pharmaceuticals PLC (LON: HIK) - Stock Analysis

   stockanalysis.com › quote › lon

   • Cached

   5 days ago · About Hikma Pharmaceuticals. Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.

3. markets.ft.com › data › equitiesHikma Pharmaceuticals PLC, HIK:LSE summary - FT.com

   markets.ft.com › data › equities

   • Cached

   5 days ago · Latest Hikma Pharmaceuticals PLC (HIK:LSE) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

   • Bid: 1,750.00
   • Low: 1,763.00

   • High: 1,807.00
   • Open: 1,786.00

   • 
   • 
   • 
   • 

4. Videos

   • 

     1:26

     youtube.com

     Hikma Pharmaceuticals - Hot or Not

     May 19, 2017

     977 Views

   • 

     1:11

     youtube.com

     Overview of Hikma injectables business

     Jun 8, 2021

     1.3K Views

   • 

     5:03

     youtube.com

     Our Impact | Hikma

     Jun 30, 2021

     288 Views

   View all

5. www.bbc.co.uk › news › topicsHikma Pharmaceuticals (HIK) Shares Price & Latest News - BBC

   www.bbc.co.uk › news › topics

   • Cached

   2 days ago · Find the latest Hikma Pharmaceuticals (HIK) stock price and news from the BBC.

6. simplywall.st › stocks › gbHikma Pharmaceuticals PLC (LON:HIK) Stock Is Going Strong But ...

   simplywall.st › stocks › gb

   • Cached

   5 days ago · Hikma Pharmaceuticals. Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

7. People also ask

   Who is Hikma Pharmaceuticals plc?

   • Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index .

   Hikma Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Hikma_Pharmaceuticals

   See all results for this question

   What is Hikma branded business segment?

   • Hikma’s branded business segment comprises the development and sales of branded generics and in-licensed patented products in the MENA region. Hikma has 499 products in 1,256 dosage strengths. Top products include Actos, Amoclan, Blopress, Omnicef, Prograf, and Suprax. Injectables

   Hikma Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Hikma_Pharmaceuticals

   See all results for this question

   How volatile is Hikma Pharmaceuticals (HIK)?

   • Volatility Over Time: HIK's weekly volatility (4%) has been stable over the past year. Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded.

   Hikma Pharmaceuticals LSE:HIK Stock Report - Simply Wall St

   simplywall.st/stocks/gb/pharmaceuticals-biotech/lse-hik/hikma-pharmaceuticals-shares

   See all results for this question

   What is the Hikma Pharmaceuticals share price?

   • Hikma Pharmaceuticals Plc Ord Shs 10P is listed on the London Stock Exchange, trading with ticker code HIK. It has a market capitalisation of £3,436 m, with approximately 220 m shares in issue. Over the last year, Hikma Pharmaceuticals share price has been traded in a range of 1059.5, hitting a high of 2234, and a low of 1174.5.

   Hikma Pharmaceuticals Share Price. HIK - Stock Quote, Charts, Trade

   www.lse.co.uk/SharePrice.asp?shareprice=HIK

   See all results for this question

8. markets.investorschronicle.markitdigital.comHikma Pharmaceuticals PLC (HIK:LSE) Share price, analysis ...

   markets.investorschronicle.markitdigital.com

   • Cached

   5 days ago · Hikma Pharmaceuticals PLC is a pharmaceutical company. The principal activities of the Company are the development, manufacture and marketing of a range of generic, branded and in-licensed pharmaceutical products. The Company operates through three segments: Injectables, Branded and Generics.

9. simplywall.st › hikma-pharmaceuticals-sharesHikma Pharmaceuticals LSE:HIK Stock Report - Simply Wall St

   simplywall.st › hikma-pharmaceuticals-shares

   • Cached

   3 days ago · Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. Show more.